| NCT ID | NCT03267615 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Vienna |
| Condition | Liver Cirrhosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2017-02-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2017-02-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients with advanced chronic liver diseases treated at the Vienna General Hospital of the Medical University of Vienna will be offered to participate in this prospective observational trial - including an optional participation in a biobank. Clinical parameters and laboratory parameters will be recorded for all patients and patients will undergo a regular follow-up schedule with clinical visits at the Vienna General Hospital. This study is linked to a biobank with serum/plasma, ascitic fluid, urine, GI tract mucosal biopsies, liver biopsies and stool collected from the study participants.
Eligibility Criteria
Inclusion Criteria: * Age \>18 years and \<100 years * Diagnosis of advanced chronic liver disease (by liver stiffness ≥10kPa, HVPG\>5mmHg or Histology F3/F4) * Written informed consent Exclusion Criteria: * Withdrawal of written informed consent
Contact & Investigator
Thomas Reiberger, M.D.
PRINCIPAL INVESTIGATOR
Medical University of Vienna
Frequently Asked Questions
Who can join the NCT03267615 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Liver Cirrhosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03267615 currently recruiting?
Yes, NCT03267615 is actively recruiting participants. Contact the research team at thomas.reiberger@meduniwien.ac.at for enrollment information.
Where is the NCT03267615 trial being conducted?
This trial is being conducted at Vienna, Austria.
Who is sponsoring the NCT03267615 clinical trial?
NCT03267615 is sponsored by Medical University of Vienna. The principal investigator is Thomas Reiberger, M.D. at Medical University of Vienna. The trial plans to enroll 10,000 participants.